Clinical Trial Update: The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics [Phase 4]

View source ↗

Summary

Phase 4 trial investigating how BCRP Q141K affects allopurinol pharmacokinetics and pharmacodynamics in chronic gout and hyperuricemia. Completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Allopurinol (Allopurinol)
• BCRP Q141K

Snippet

Sponsor: University of California, San Francisco | Conditions: Chronic Gout, Hyperuricemia | Phase 4 | Status: COMPLETED | Results posted: 2020-06-23